ETFs Holding DRNA »    DRNA Historical Stock Prices »
DRNA News Video: Mon, Nov 2, 2015, 1:15 PM — Monday Sector Leaders: Biotechnology, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Dicerna Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of subcutaneously delivered ribonucleic acid interference (RNAi)-based pharmaceuticals using its GalXC™ RNAi platform for the treatment of diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases. Co.'s three main programs are: DCR-PHXC for the treatment of primary hyperoxaluria; a program for an undisclosed rare disease; and DCR-HBVS for the treatment of chronic hepatitis B virus infection. Co. also has a program for the treatment of hypercholesterolemia, for which a clinical candidate, DCR-PCSK9, has been selected. Self directed investors in Dicerna Pharmaceuticals Inc will be interested in keeping up with all Dicerna Pharmaceuticals Inc news they can find, both DRNA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on DRNA. At RediNews, we simplify this task by presenting both DRNA news releases originating from Dicerna Pharmaceuticals Inc itself, and DRNA news from a variety of media outlets. Visitors can browse this news online and through our DRNA RSS news feed.


DRNA News — Articles, Videos, & Press Releases

First Week of January 2020 Options Trading For Dicerna Pharmaceuticals (DRNA)
Tuesday, May 21, 2019, 11:02 AM — Stock Options Channel
Look Under The Hood: XBI Has 50% Upside
Monday, May 13, 2019, 8:14 AM — ETF Channel
Dicerna Pharmaceuticals Becomes Oversold (DRNA)
Friday, May 10, 2019, 11:59 AM — Dividend Channel
We Did The Math KOMP Can Go To $36
Friday, April 12, 2019, 7:51 AM — ETF Channel
4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics
Thursday, April 11, 2019, 7:27 AM — Zacks
Interesting DRNA Put And Call Options For May 17th
Monday, April 1, 2019, 10:41 AM — Stock Options Channel
Analysts Anticipate DWAS Will Reach $56
Wednesday, March 6, 2019, 8:29 AM — ETF Channel
The Math Shows TUSA Can Go To $37
Tuesday, January 29, 2019, 8:00 AM — ETF Channel
First Week of DRNA February 15th Options Trading
Friday, January 4, 2019, 10:55 AM — Stock Options Channel
The Math Shows DWAS Can Go To $62
Friday, December 28, 2018, 9:44 AM — ETF Channel
RSI Alert: Dicerna Pharmaceuticals (DRNA) Now Oversold
Thursday, December 20, 2018, 12:31 PM — Dividend Channel
Dicerna Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for DRNA
Friday, December 7, 2018, 11:40 AM — Market News Video
Analysts Forecast 20% Gains Ahead For TUSA
Tuesday, November 27, 2018, 7:37 AM — ETF Channel
DRNA Makes Notable Cross Below Critical Moving Average
Wednesday, November 14, 2018, 4:56 PM — Market News Video
First Week of December 21st Options Trading For Dicerna Pharmaceuticals (DRNA)
Tuesday, October 30, 2018, 10:47 AM — Stock Options Channel
Dicerna Pharmaceuticals Stock Sees Short Interest Expand By 14%
Thursday, October 25, 2018, 12:08 PM — Market News Video
Analysts Anticipate 24% Gains Ahead For DWAS
Wednesday, October 24, 2018, 7:37 AM — ETF Channel
Short Interest Jumps 10.6% For DRNA
Wednesday, October 10, 2018, 2:17 PM — Market News Video
First Week of November 16th Options Trading For Dicerna Pharmaceuticals (DRNA)
Monday, October 1, 2018, 10:48 AM — Stock Options Channel
DRNA Crosses Above Average Analyst Target
Friday, August 17, 2018, 7:41 AM — ETF Channel
Commit To Purchase Dicerna Pharmaceuticals At $10, Earn 13.4% Annualized Using Options
Wednesday, August 8, 2018, 11:46 AM — Stock Options Channel
DRNA Crosses Above Average Analyst Target
Monday, July 9, 2018, 7:49 AM — ETF Channel
DRNA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

AIQ News

RediNews asks: are you the content manager in charge of web publishing content for web site stock quote, stock chart, forex, pages with historical price data for the markets, or other types of custom financial content like pink sheets symbols, option symbols, and stock portfolio pages? Then you should add RediNews RSS feeds to your arsenal of free financial website content and financial tools, adding another element of dynamic stock content to your pages with a constantly updating menu of recent news headlines for individual stocks and market sectors. So give our financial news feed a try by clicking the RSS icon for any news page (which will look like this): .

DRNA News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.